Stevens J Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STEVENS J, and what generic and branded alternatives to STEVENS J drugs are available?
STEVENS J has twelve approved drugs.
Drugs and US Patents for Stevens J
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stevens J | CINACALCET HYDROCHLORIDE | cinacalcet hydrochloride | TABLET;ORAL | 204364-003 | Dec 2, 2021 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Stevens J | ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE | aspirin; caffeine; orphenadrine citrate | TABLET;ORAL | 074988-001 | Apr 30, 1999 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Stevens J | DEFERASIROX | deferasirox | TABLET;ORAL | 210727-003 | Jun 15, 2020 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.